English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Leandro R. D. Sanz1, Nicolas Lejeune1,2,3, Aurore Thibaut1, Séverine Blandiaux1, Johan Stender4, Neal Farber5, Ross Zafonte6,7, Steven Laureys1, Olivia Gosseries1 1. Coma Science Group, GIGA Consciousness, University and University Hospital of Liège, Liège, Belgium 2. CHN William Lennox, Groupe Hospitalier Saint-Luc, Ottignies, Belgium 3. Institute of Neurosciences, UCLouvain, Brussels, Belgium 4. Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark 5. NeuroHealing Pharmaceuticals Inc., Waban, Massachusetts, USA 6. Harvard Medical School, Department of Physical Medicine and Rehabilitation, Boston, Massachusetts, USA 7. Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Brigham and Women’s Hospital Boston, Massachusetts, USA, Corresponding author: Leandro R. D. Sanz, leandro.sanz@uliege.be, +3243663915

frontiers in neuroscience

Treating severely brain-injured patients with apomorphine: study protocol for a double blind randomized placebo-controlled trial using behavioral and neuroimaging assessments